CN1090948C - Medicine powder for prostatitis - Google Patents

Medicine powder for prostatitis Download PDF

Info

Publication number
CN1090948C
CN1090948C CN97107318A CN97107318A CN1090948C CN 1090948 C CN1090948 C CN 1090948C CN 97107318 A CN97107318 A CN 97107318A CN 97107318 A CN97107318 A CN 97107318A CN 1090948 C CN1090948 C CN 1090948C
Authority
CN
China
Prior art keywords
prostatitis
medicine
radix
rhizoma
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97107318A
Other languages
Chinese (zh)
Other versions
CN1166355A (en
Inventor
徐相廷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97107318A priority Critical patent/CN1090948C/en
Publication of CN1166355A publication Critical patent/CN1166355A/en
Application granted granted Critical
Publication of CN1090948C publication Critical patent/CN1090948C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to Chinese patent medicine prostatitis powder for treating acute and chronic prostatitis andprostate hyperplasia, which is powder prepared from pure Chinese medicines as raw materials, such as cassia bark, common anemarrhena rhizome, indian bread, milkvetch root, rhubarb, sodium sulfate, yellow-corktree bark, pangolin scale, peach seed, twotoothed achyranthes root, yam rhizome, lygodium, christina loosestrife, talc, corydalis tuber and lychee seed. The present invention has obvious curative effect on treating prostatitis andprostate hyperplasia and has no toxic side effect in clinical operation.

Description

Medicine powder for prostatitis
The present invention relates to a kind of Chinese patent medicine medicine powder for prostatitis for the treatment of acute prostatitis, chronic prostatitis, prostatic hyperplasia, is the powdery Chinese patent medicine made from pure Chinese crude drug.
At present, prostatitis and prostatic hyperplasia are the adult commonly encountered diseases of male, frequently-occurring disease, and with regard to its symptom, prostatitis shows as that frequent micturition, urgent micturition, dysurea, chaude-pisse, pouring are dripped puckery pain or twinge when urinating.But at ordinary times, show as the symptom of suffering from a deficiency of the kidney more, have fat sample white liquid to ooze behind the urine, libido reduction, sexual impotence, premature ejaculation, soreness of the waist and knees, waist and sacrum pain, lower abdomen weighs down the dull pain that expands, testis dragging pain, insomnia, forgetful dreaminess, lassitude, Light-headedness etc.Prostatic hyperplasia also makes that nocturia increases, trouble urinating, and urination time is long, and when further increasing, acute urinary retention appears in the compressing urethra, can not pull urine, and lower abdominal distention pain, uneasy in either sitting or lying are identical with the difficulty in urination symptom of the traditional Chinese medical science.With regard to its treatment, the Western medicine curative effect is undesirable, and treatment by Chinese herbs does not still have specific medicament.
Purpose of the present invention just is: invent a kind of Chinese patent medicine medicine powder for prostatitis that prostatitis and prostatic hyperplasia have the pure Chinese crude drug of better curative effect to make for the treatment of.
The present invention realizes its purpose like this: the powdery Chinese patent medicine that this powder system makes with pure Chinese crude drug, the former medicine Chinese crude drug of forming this powder is Cortex Cinnamomi, the Rhizoma Anemarrhenae, Poria, the Radix Astragali, Radix Et Rhizoma Rhei, Natrii Sulfas, Cortex Phellodendri, Squama Manis, Semen Persicae, Radix Achyranthis Bidentatae, Bi , Spora Lygodii, Herba Lysimachiae, Talcum, Rhizoma Corydalis, Semen Litchi.
The present invention can also realize purpose like this: the dosage (in gram) of the dried Chinese crude drug of former medicine of its per 258 gram powders is: Cortex Cinnamomi 4-10, Rhizoma Anemarrhenae 8-12, Poria 12-36, Radix Astragali 22-50, Radix Et Rhizoma Rhei 6-14, Natrii Sulfas 8-12, Cortex Phellodendri 10-20, Squama Manis 8-12, Semen Persicae 8-12, Radix Achyranthis Bidentatae 12-20, Bi  8-18, Spora Lygodii 10-20, Herba Lysimachiae 18-32, Talcum 20-34, Rhizoma Corydalis 6-14, Semen Litchi 10-30.
Further specified below in conjunction with embodiment, but be not limited only to this.
Embodiment one
1, the compatibility dosage of this medicine.This powder is raw material with Cortex Cinnamomi, the Rhizoma Anemarrhenae, Poria, the Radix Astragali, Radix Et Rhizoma Rhei, Natrii Sulfas, Cortex Phellodendri, Squama Manis, Semen Persicae, Radix Achyranthis Bidentatae, Bi , Spora Lygodii, Herba Lysimachiae, Talcum, Rhizoma Corydalis, Semen Litchi, is processed into the powdery Chinese patent medicine.The dried Chinese crude drug dosage of former medicine (in gram) of its per 258 gram powders is: Cortex Cinnamomi 10, the Rhizoma Anemarrhenae 8, Poria 12, the Radix Astragali 50, Radix Et Rhizoma Rhei 6, Natrii Sulfas 8, Cortex Phellodendri 20, Squama Manis 12, Semen Persicae 12, Radix Achyranthis Bidentatae 20, Bi  8, Spora Lygodii 10, Herba Lysimachiae 18, Talcum 20, Rhizoma Corydalis 14, Semen Litchi 30.
2, the manufacture method of medicine.Above-mentioned drying in the sun Chinese crude drug Cortex Cinnamomi, the Rhizoma Anemarrhenae, Poria, the Radix Astragali, Radix Et Rhizoma Rhei, Natrii Sulfas, Cortex Phellodendri, Squama Manis, Semen Persicae, Radix Achyranthis Bidentatae, Bi , Spora Lygodii, Herba Lysimachiae, Talcum, Rhizoma Corydalis, Semen Litchi are measured by dosage, pulverizing with general Chinese crude drug pulverizer is the end, be distributed into bag, every bag 6 grams get final product.During production in enormous quantities, can get final product according to aforementioned proportion expansion.
3, the using method of medicine, taboo and preservation.Every day for oral administration 3 times, each 6 grams, 10 is a course of treatment, serve on two courses of treatment and imitates good.Do not avoid, be kept at shady and cool dry place.
4, clinical result of use.With this medicine to acute, chronic prostatitis and prostatic hyperplasia 52 example treatments from the whole nation, after two courses of treatment, on ground, city hospital is to the prostatic fluid routine examination, rectal touch inspection, 10 examples of wherein fully recovering, produce effects 35 examples, effective 5 examples, invalid 2 examples, total effective rate 96.1%, in clinical, find no the toxic and side effects reaction.
Embodiment two
1, compatibility of drugs dosage.Make raw material with pure Chinese crude drug Cortex Cinnamomi, the Rhizoma Anemarrhenae, Poria, the Radix Astragali, Radix Et Rhizoma Rhei, Natrii Sulfas, Cortex Phellodendri, Squama Manis, Semen Persicae, Radix Achyranthis Bidentatae, Bi , Spora Lygodii, Herba Lysimachiae, Talcum, Rhizoma Corydalis, Semen Litchi, be processed into powder, the dried Chinese crude drug dosage of former medicine (in gram) of the powder of its per 258 grams is: Cortex Cinnamomi 6, the Rhizoma Anemarrhenae 10, Poria 20, the Radix Astragali 30, Radix Et Rhizoma Rhei 10, Natrii Sulfas 10, Cortex Phellodendri 15, Squama Manis 10, Semen Persicae 10, Radix Achyranthis Bidentatae 15, Bi  15, Spora Lygodii 15, Herba Lysimachiae 30, Talcum 30, Rhizoma Corydalis 12, Semen Litchi 20.
2, manufacture method of medicine, using method, taboo and preservation are with example one.
3, clinical result of use.With this medicine acute and chronic prostatitis and prostatic hyperplasia 64 examples from the whole nation are treated, after two courses of treatment, through ground, city hospital does examination of prostatic fluid, rectal touch inspection, 28 examples of wherein fully recovering, produce effects 29 examples, effective 6 examples, invalid 1 example, total effective rate 98.4%, the clinical toxic and side effects that finds no is reacted.
Embodiment three
1, compatibility of drugs dosage.Get pure Chinese crude drug Cortex Cinnamomi, the Rhizoma Anemarrhenae, Poria, the Radix Astragali, Natrii Sulfas, Radix Et Rhizoma Rhei, Cortex Phellodendri, Squama Manis, Semen Persicae, Radix Achyranthis Bidentatae, Bi , Spora Lygodii, Herba Lysimachiae, Talcum, Rhizoma Corydalis, Semen Litchi and make raw material, dried medical material dosage of former medicine (in gram) of its per 258 gram powders is: Cortex Cinnamomi 4, the Rhizoma Anemarrhenae 12, Poria 36, the Radix Astragali 22, Radix Et Rhizoma Rhei 14, Natrii Sulfas 12, Cortex Phellodendri 10, Squama Manis 8, Semen Persicae 8, Radix Achyranthis Bidentatae 12, Bi  18, Spora Lygodii 20, Herba Lysimachiae 32, Talcum 34, Rhizoma Corydalis 6, Semen Litchi 10.
2, manufacture method of medicine, using method, taboo and preservation are with example one.
3, clinical result of use.With this medicine to 62 routine prostatitis and prostatic hyperplasia patient treatment from the whole nation, after two courses of treatment, on ground, city-level hospital carries out examination of prostatic fluid, rectal touch is checked, 12 examples of wherein fully recovering, produce effects 38 examples, effective 9 examples, invalid 3 examples, total effective rate 95.1% finds no the toxic and side effects reaction clinically.
Pharmacology and effect analysis-by-synthesis.Acute, chronic prostatitis and prostatic hyperplasia, with regard to its cause of disease, be suffer from a deficiency of the kidney with turbid damp in accumulate, disease has the stagnation of QI for a long time and often and holds the stasis of blood under the arm, causes the different disease of degree.To 178 routine patient treatments, wherein the course of disease is the shortest 2 years with this medicine, and is the longest more than 12 years, minimum 41 years old of age, maximum 76 years old, wherein acute prostatitis 51 examples, chronic prostatitis 85 examples, prostatic hyperplasia 42 examples are after two course of therapy, on ground, city-level hospital does examination of prostatic fluid and rectal touch inspection, wherein recovery from illness (is a clinical symptom disappearance, it is normal that prostatic part recovers, examination of prostatic fluid, the rectal touch inspection is normal) 50 examples; Produce effects (cardinal symptom disappears, and prostatic part is no abnormal, and prostatic fluid and rectal touch inspection are normal substantially, have repeatedly slightly) 102 examples; Effectively (cardinal symptom is clearly better, and prostatic part does not have obvious tenderness, but leave rhabdion, examination of prostatic fluid is tending towards normally, but do not consolidate) 20 examples; It is invalid that (symptom repeatedly; Body of prostate has rhabdion or tenderness, and it is normal that examination of prostatic fluid does not recover) 6 examples.Average total effective rate 96.6%, clinical observation finds no toxicity.With regard to its treatment, with warming the kidney and strengthening the spleen, clearing away heat-damp and promoting diuresis, change turbid treating stranguria, the clots absorbing eliminating stagnation, carrying out dialectical treatment is principle, this medicine carries out the compatibility dosage in view of the above, and wherein Cortex Cinnamomi energy promoting the flow of QI-blood by warming the meridian, blood circulation promoting competent silt increase coronary flow, the expansion peripheral blood vessel has strong bactericidal action, can mend fire from the gater of life, guiding fire to origin is arranged, the disappear merit of the moon of Yiyang, it is former that the Rhizoma Anemarrhenae is grown the change of lung meridian, rush down the kidney fire, moisturize laxation; The Poria promoting diuresis with drugs of tasteless flavour, sensible pathogenic heat, reinforcing the heart spleen lung benefiting, the mind tranquilizing and the heart calming of removing; Radix Astragali tonifying Qi and lifting yang, the diuresis detumescent, the heart tonifying blood vessel dilating improves cutaneous circulation and nutriture, enhancing body's immunological function, infection; Cortex Phellodendri has heat clearing and damp drying, and eliminating fire and detoxication is treated the merit of skin ulcer, and antimicrbial power is strong, and dysentery bacterium, gonococcus, trichomonas vaginitis are had inhibitory action; The Radix Et Rhizoma Rhei removing pathogenic heat from blood and toxic substance from the body, the clots absorbing removing mass rushes down down, astringing to arrest bleeding, spasmolytic, function of gallbladder promoting, antibiotic, antiviral; Natrii Sulfas has and rushes down down intestinal stasis relieving, and moistening for dryness and softening hard mass reducing swelling and alleviating pain, guiding blood stasis are from the descending merit of intestinal; Squama Manis is apt to away scurry, and merit is specially in loosing, interior logical internal organs, the meridians of passing through inside, and the promoting the circulation of blood removing blood stasis with potent drugs, activating collaterals and eliminating stagnation has the merit at the place of through disease; Semen Persicae has blood stasis removing and clots absorbing, laxation relieving constipation, anticoagulant effect; The Radix Achyranthis Bidentatae blood circulation promoting and blood stasis dispelling, anti-inflammatory analgetic, inducing diuresis for treating stranguria syndrome, to draw all medicines descending; Bi  dampness removing goes turbid, and the eliminating impediment that dispels the wind is controlled nebulousurine, pains in the penis, sharp bladder urethra, the stranguria marked by chyluria due to the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels turbid damp; The pain relieving of Spora Lygodii inducing diuresis for treating stranguria syndrome is used for stranguria marked by chyluria, stranguria caused by urinary stone, sand Stranguria, pyretic stranguria etc.; The Talcum clearing away heat and promoting diuresis is treating stranguria; Rhizoma Corydalis is invigorated blood circulation, promoting the circulation of QI, pain relieving; The Semen Litchi warming middle-JIAO, regulate the flow of vital energy, pain relieving, control orchiodynia, vim and vigour pain; The Herba Lysimachiae clearing heat for detumescence, the inducing diuresis for treating stranguria syndrome pain relieving is used for the puckery pain of all pouring etc.Therefore, fill a prescription with this, have turbid treating stranguria, the clots absorbing eliminating stagnation of heat clearing away toxin expelling, anti-inflammation and sterilization, warming the kidney and strengthening the spleen, ascending the clear and descending the turbid, change, promoting blood circulation and stopping pain, the effect such as be open to the custom of regulating the flow of vital energy can enhancing body quality and immunologic function, regulates function, conditioning strengthens the function of prostate physiological function and himself resist the disease, thereby evident in efficacy, and by above-mentioned compatibility, there is not toxic and side effects in medicine.

Claims (1)

1, a kind of medicine medicine powder for prostatitis for the treatment of prostatitis and prostatic hyperplasia is characterized in that: the dried Chinese crude drug in the former medicine of per 258 gram powders in the proportioning of gram is:
Cortex Cinnamomi 4-10, Rhizoma Anemarrhenae 8-12, Poria 12-36,
Radix Astragali 22-50, Radix Et Rhizoma Rhei 6-14, Natrii Sulfas 8-12,
Cortex Phellodendri 10-20, Squama Manis 8-12, Semen Persicae 8-12,
Radix Achyranthis Bidentatae 12-20, Bi  8-18, Spora Lygodii 10-20,
Herba Lysimachiae 18-32, Talcum 20-34, Rhizoma Corydalis 6-14,
Semen Litchi 10-30.
CN97107318A 1997-01-11 1997-01-11 Medicine powder for prostatitis Expired - Fee Related CN1090948C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97107318A CN1090948C (en) 1997-01-11 1997-01-11 Medicine powder for prostatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97107318A CN1090948C (en) 1997-01-11 1997-01-11 Medicine powder for prostatitis

Publications (2)

Publication Number Publication Date
CN1166355A CN1166355A (en) 1997-12-03
CN1090948C true CN1090948C (en) 2002-09-18

Family

ID=5169454

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97107318A Expired - Fee Related CN1090948C (en) 1997-01-11 1997-01-11 Medicine powder for prostatitis

Country Status (1)

Country Link
CN (1) CN1090948C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071126C (en) * 1998-10-14 2001-09-19 马国勇 Chinese medicine preparation for curing hyperplasia of prostate and preparing process thereof
US6790464B2 (en) * 2003-01-16 2004-09-14 Healthaid Enterprise Pte. Ltd. Herbal compositions for prostate conditions
CN103638072A (en) * 2013-11-26 2014-03-19 宋爱民 Traditional Chinese medicine preparation for treating chronic prostatitis caused by blood-stasis obstructed in interior
CN106177281A (en) * 2016-08-18 2016-12-07 黄逢雨 A kind of Chinese medicine composition treating prostatic hyperplasia
CN110772623A (en) * 2019-12-18 2020-02-11 张吉方 Traditional Chinese medicine for treating prostate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083368A (en) * 1992-08-31 1994-03-09 四平市第一人民医院 A kind of prescription of pills for prostate disease and manufacturing process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083368A (en) * 1992-08-31 1994-03-09 四平市第一人民医院 A kind of prescription of pills for prostate disease and manufacturing process

Also Published As

Publication number Publication date
CN1166355A (en) 1997-12-03

Similar Documents

Publication Publication Date Title
CN102743738B (en) External use navel spreading sparadrap for treating gastrointestinal dysfunction
CN102526616B (en) Chinese medicinal herb pills for treating cholecystitis and gallstone
CN102228603B (en) Chinese medicine for treating retention of urine
CN101862428B (en) Chinese medicament for treating benign prostatic hyperplasia
CN104324328A (en) Traditional Chinese medicine composition for ileus and preparation method of traditional Chinese medicine composition
CN103520680B (en) The Chinese medicine for the treatment of acute heart failure
CN103417805B (en) Medicine for treating prostatitis and preparation method thereof
CN1090948C (en) Medicine powder for prostatitis
CN101607067B (en) Traditional Chinese medicine preparation for treating cholelithiasis and preparation method thereof
CN103735921B (en) A kind of medicine for the treatment of urethritis and preparation method thereof
CN103655931B (en) Chinese medicine composition for the treatment of ureteral calculus and preparation method thereof
CN102552576A (en) Chinese herbal pill for curing renal calculus
CN101700390B (en) Oral traditional Chinese medicine composition for treating fatty liver
CN1299728C (en) Capsules of Tokyo violet, dandelion and flavescent sophora root and their making method
CN1241596C (en) Oral Chinese traditional medicine preparation for treating cystitis
CN101371900A (en) Orally taken Chinese medicinal composition for treating constipation
CN101961481A (en) Traditional Chinese medicine for treating liver-gallbladder qi stagnation type cholecystitis and preparation method thereof
CN101057921B (en) Traditional Chinese medicine capsule for treating prostatic hyperplasia
CN102743589B (en) Preparation method of Chinese medicine irrigation solution for treating garlic addiction type trichomonas vaginitis
CN1283282C (en) Chinese traditional medicine for treating appendicitis
CN101085338A (en) Traditional Chinese medicine preparation for curing uric acid nephritis
CN104352950A (en) Traditional Chinese medicine composition for treating gynecological inflammation
CN104491516A (en) Traditional Chinese medicine for treating kidney stone
CN103585431A (en) Traditional Chinese medicine composition for curing type I diabetes mellitus
CN103520638A (en) Traditional Chinese medicine compound composition for treating prostatic hyperplasia, and preparation method and application thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee